TB diagnostics in India: From importation and imitation to innovation will be held at the St. John’s Research Institute in Bangalore, India on 25-26 August 2011. The conference is sponsored by McGill University & Global Health Strategies with technical support from the Bill & Melinda Gates Foundation, the Foundation for Innovative New Diagnostics, and the International Centre for Genetic Engineering and Biotechnology (ICGEB), India.
It will convene industry leaders, innovative thinkers, researchers, funders, TB controllers and policy makers to stimulate increased industry/biotech engagement in diagnostic innovations that can help TB control in India and elsewhere. Sessions will focus on topics such as market size for TB diagnostics, IVD market analysis and value chain, target product profiles and market needs, frugal innovation and affordable diagnostics, intellectual property issues, regulation of diagnostics, sources of funding, prize models, business models for engaging private sector, scientific obstacles for R&D, barriers to innovation in India, improving academia-industry relations, and role of emerging economies and BRICS in the next wave of TB innovations.
Click here for more information and to link to the registration form. Space is limited: Industry/biotech participants and TB diagnostic developers will be given preference.